Literature DB >> 34051624

Treatment of progressive multifocal Leukoencephalopathy associated with idiopathic lymphocytopenia with Nivolumab.

Laura Fischbach1, Tobias Bauer2, Theodor Rüber3, Marcus Grobe-Einsler4, Aileen Sitter5, Alexander Radbruch6, Oliver Kaut7.   

Abstract

Entities:  

Keywords:  Activation; Cerebellar syndrom.; Immune checkpoint-inhibitor; Immunomodulation; JC-virus; Neuroimmunology; T cell

Year:  2021        PMID： 34051624     DOI： 10.1016/j.jns.2021.117503

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  2 in total

Review 1.  Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.

Authors:  Sydney Corey; Bryan R Smith; Irene C M Cortese
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-01       Impact factor: 5.495

Review 2.  Advances in Treatment of Progressive Multifocal Leukoencephalopathy.

Authors:  Raphaël Bernard-Valnet; Igor J Koralnik; Renaud Du Pasquier
Journal:  Ann Neurol       Date:  2021-09-07       Impact factor: 11.274
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.